Skip to main content
. 2020 Mar 6;9(4):222–229. doi: 10.1002/psp4.12498

Figure 1.

Figure 1

Summary of type 2 diabetes mellitus subject characteristics: (a) daily MPG, (b) eGFR, and (c) glucose kidney filtration flux in the pooled data set for dapagliflozin (red, n = 7), empagliflozin (blue, n = 14), and canagliflozin (green, n = 11). eGFR, estimated glomerular filtration rate; MPG, mean daily plasma glucose.